Aradigm Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 14

Aradigm General Information

Description

Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company has respiratory inhalation products in preclinical and clinical development for the treatment of cystic fibrosis, bronchiectasis, biodefense, and tobacco smoking cessation. It derives revenue from the grants, collaboration agreements, and feasibility studies.

Contact Information

Website
www.aradigm.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • 3929 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Corporate Office
  • 3929 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (510)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aradigm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aradigm‘s full profile, request access.

Request a free trial

Aradigm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered b
Drug Discovery
Hayward, CA
23 As of 2017

Paris, France
 

Dallas, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aradigm Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sanofi Corporation Paris, France
United Biomedical Venture Capital-Backed Dallas, TX
Acorda Therapeutics Corporate Backed or Acquired Ardsley, NY
Merrimack Pharmaceuticals Formerly VC-backed Cambridge, MA
Ampio Pharmaceuticals Corporation Englewood, CO
You’re viewing 5 of 40 competitors. Get the full list »

Aradigm Patents

  • 573

    Total Documents Applications and Grants

  • Total Patents Families

  • 134

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Aradigm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015244399-B2 Liposomes that form drug nanocrystals after freeze-thaw Inactive 08-Apr-2014
AU-2015244399-A1 Liposomes that form drug nanocrystals after freeze-thaw Active 08-Apr-2014
AU-2015244275-B2 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Inactive 08-Apr-2014
EP-3129008-A1 Liposomes that form drug nanocrystals after freeze-thaw Inactive 08-Apr-2014
AU-2015244275-A1 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Active 08-Apr-2014 A61K31/496
To view Aradigm’s complete patent history, request access »

Aradigm Executive Team (10)

Name Title Board Seat
James Blanchard Principal Scientist, Preclinical Development
You’re viewing 1 of 10 executive team members. Get the full list »

Aradigm Board Members (6)

Name Representing Role Since
Self Board Member
You’re viewing 1 of 6 board members. Get the full list »

Aradigm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aradigm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aradigm‘s full profile, request access.

Request a free trial

Aradigm ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Aradigm’s complete esg history, request access »

Aradigm FAQs

  • When was Aradigm founded?

    Aradigm was founded in 1991.

  • Where is Aradigm headquartered?

    Aradigm is headquartered in Hayward, CA.

  • What is the size of Aradigm?

    Aradigm has 23 total employees.

  • What industry is Aradigm in?

    Aradigm’s primary industry is Drug Discovery.

  • Is Aradigm a private or public company?

    Aradigm is a Private company.

  • What is Aradigm’s current revenue?

    The current revenue for Aradigm is .

  • How much funding has Aradigm raised over time?

    Aradigm has raised $178M.

  • Who are Aradigm’s investors?

    Grifols and First Eagle Investments have invested in Aradigm.

  • Who are Aradigm’s competitors?

    Sanofi, United Biomedical, Acorda Therapeutics, Merrimack Pharmaceuticals, and Ampio Pharmaceuticals are some of the 40 competitors of Aradigm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »